๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› PET/CT
Clinical trial register · China

PET/CT Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xiamen 7 Wuhan 5 Shanghai 5 Beijing 3 Hefei 1
Narrow the registerReset
Recruitment status
Phase
Site location
Xiamen7 Wuhan5 Shanghai5 Beijing3 Hefei1
All 9 locations
Target enrolment
to

PET/CT trials in China

22 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
DLL3-Targeted PET/CT in Small Cell Lung Cancer
NCT07677787PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3
The First Affiliated Hospital of Xiamen University
Not applicable
20
Xiamen
2026-05-09
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
NCT07487883Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CT
Peking University People's Hospital
Observational
80
Beijing
2026-03-18
Not yet open
Evaluation of the Diagnostic Efficacy of a ฮฑvฮฒ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors
NCT07385950PET / CT, Solid Tumors, Adult
Zhongnan Hospital
Observational
100
Wuhan
2026-01-15
Recruiting
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
NCT07458906DLL3-expressing Tumors, PET / CT, Neuroendocrine Cancer
The First Affiliated Hospital of Xiamen University
Not applicable
60
Xiamen
2025-12-01
Recruiting
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
NCT07243873Lung Cancer, PET-CT
Shanghai Pulmonary Hospital, Shanghai, China
Observational
10,000
Zunyi, Jiangxi, Shanghai, Ningbo
2025-12-01
Recruiting
68Ga-XACP3 PET/CT in Prostate Cancer
NCT07242014Prostate Cancer, PET/CT, ACP3
The First Affiliated Hospital of Xiamen University
Not applicable
60
Xiamen
2025-09-01
Recruiting
Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma
NCT07137052Nasopharyngeal Carcinoma (NPC), PET / CT
The First Affiliated Hospital of Xiamen University
Observational
732
Xiamen
2025-08-30
Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
NCT07498933Non-Small Cell Lung Cancer, PET/CT, Neoadjuvant Therapy
Peking University People's Hospital
Observational
200
Beijing
2025-06-03
Recruiting
PET/CT for Trop2 ADC Response Evaluation NSCLC
NCT07151898NSCLC, Trop2, PET/CT
The First Affiliated Hospital of Xiamen University
Observational
50
Xiamen
2025-05-01
By invitation
Breast Cancer PET/CT Imaging With 68Ga-pAKTi
NCT06943313Breast Cancers, PIK3CA Mutation-Related Tumors, PI3K Pathway Activated Tumors, PET / CT
Fudan University
Observational
20
Shanghai
2025-04-21
Not yet open
Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy
NCT06916442PET/CT, Solid Tumors, Adult, Solid Tumors, Advanced Solid Tumors
Zhongnan Hospital
Observational
200
Wuhan
2025-04-01
Recruiting
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334Prostate Cancer, PET/CT
Anhui Provincial Hospital
Phase EARLY_PHASE1
30
Hefei
2024-12-19
Recruiting
68Ga-MY6349 PET/CT in Solid Tumors
NCT07046702Solid Tumor, Trop2, PET/CT
The First Affiliated Hospital of Xiamen University
Observational
300
Xiamen
2024-12-10
Recruiting
PET/CT for Trop2 ADC Response Evaluation Cancers
NCT07046689Breast Cancer, Trop2, PET/CT
The First Affiliated Hospital of Xiamen University
Observational
50
Xiamen
2024-11-01
By invitation
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients
NCT07162779PET CT
Affiliated Hospital of Jiangnan University
Not applicable
5
Wuxi
2024-10-29
Recruiting
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
NCT06519760Carbonic Anhydrase IX, PET-CT, Clear Cell Renal Cell Carcinoma
Peking University First Hospital
Not applicable
200
Beijing
2024-07-30
Recruiting
The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer
NCT06623487Carcinoma, Non-Small-Cell Lung, PET / CT, Neoadjuvant Immunotherapy
Ruijin Hospital
Observational
30
Shanghai
2024-07-19
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160PET / CT, Lung Carcinoma, Immunotherapy
Ruijin Hospital
Observational
30
Shanghai
2024-06-20
Recruiting
Integrin ฮฑvฮฒ6-targeted PET in Malignant Tumors
NCT05835570Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic
Zhongnan Hospital
Observational
200
Wuhan
2023-01-01
Recruiting
CXCR4-targeted PET/CT Imaging in Hematological Malignancies
NCT05255926CXCR4, PET/CT, Hematological Malignancy
Zhongnan Hospital
Not applicable
300
Wuhan
2022-03-01
Recruiting
68Ga-FAPI PET/CT in Malignant Tumors
NCT05034146Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm
Zhongnan Hospital
Not applicable
500
Wuhan
2021-02-23
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/pet-ct

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies listing the condition PET/CT.

How many PET/CT trials are recruiting in China?

18 of the 22 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (PET/CT), 22 studies
PhaseStudiesRecruitingShare
Observational141163.6%
Not applicable7631.8%
Phase EARLY_PHASE1114.5%

Most active sponsors

Lead sponsors with the most studies (PET/CT)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Xiamen University77
Zhongnan Hospital53
Peking University People's Hospital22
Ruijin Hospital22
Affiliated Hospital of Jiangnan University10
Anhui Provincial Hospital11
Fudan University10
Kunwei Shen11
Peking University First Hospital11
Shanghai Pulmonary Hospital, Shanghai, China11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.